Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivationBing Na(Rutgers, The State University of New Jersey), Darren R. Carpizo(Rutgers, The State University of New Jersey)npj Breast CancerApril 15, 201910.1038/s41523-019-0110-1Cited by 60SaveCiteExport RISWatch citationsRelated PapersTransgenic Expression of Entire Hepatitis B Virus in Mice Induces Hepatocarcinogenesis Independent of Chronic Liver Injury|PLoS ONE|2011|46